2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

B. Vellingiri, D. Venkatesan (Coimbatore, India)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: Sequencing of single human nigral dopaminergic neurons for somatic copy number variants

D. Perez-Rodriguez, M. Kalyva, S. Santucci, K. Mokretar, M. Leija-Salazar, A. Schapira, T. Lashley, J. Holton, C. Proukakis (London, United Kingdom)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD)

M. Figorilli, P. Pisanu, M. Mascia, M. Meloni, R. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, ML. Fantini, M. Puligheddu (Monserrato, Italy)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Sex-specific effect of ATXN2 rs7969300 polymorphism on age at onset in Spinocerebellar Ataxia type 2

L. Almaguer-Mederos, S. Gispert, D. Almaguer-Gotay, R. Aguilera-Rodríguez, Y. González-Zaldívar, Y. Vázquez-Mojena, D. Cuello-Almarales, D. Palenzuela, G. Auburger (Havana, Cuba)

Ataxia · Les Muses, Level 3

1:45pm-3:15pm: Share the Care: Supporting Parkinson’s Disease Caregivers Through Peer Mentoring

J. Lee, E. Wallace, C. Niemet, S. Hess, B. Ouyang, J. Wilkinson, D. Hall, J. Chodosh, J. Fleisher (Philadelphia, PA, USA)

Caregiver Burden · Les Muses Terrace, Level 3

1:45pm-3:15pm: Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)

Psychiatric Manifestations · Les Muses Terrace, Level 3

1:45pm-3:15pm: Short term use of bromocriptine for treatment of Parkinson’s disease during pregnancy

D. Taylor, P. Lewitt (West Bloomfield, MI, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson’s disease

X. Zhang, M. Zou, R. Liu, J. Wang, Q. Fan (Wenzhou, China)

Genetics · Les Muses Terrace, Level 3